tirzepatide obesity nejm vs Semaglutide for – NEJM, May 2025 Relevant to endocrinology, internal medicine, cardiology, obesity medicine • Tirzepatide: −20.2% weight loss at 72 wks • Semaglutide: −13.7% • Greater waist reduction First head-to-head study in people
Pay in 4 interest-free payments of $6.09 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29









.png)








![Henry Meds Semaglutide Review [2026]](https://innerbody.imgix.net/henry-semaglutide.jpg?auto=format,compress&fit=max&w=826&q=75)






